Macquarie Group Ltd. raised its position in Balchem Corporation (NASDAQ:BCPC) by 47.1% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 351,899 shares of the basic materials company’s stock after buying an additional 112,703 shares during the period. Macquarie Group Ltd. owned approximately 1.10% of Balchem Corporation worth $27,346,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of the business. Fred Alger Management Inc. boosted its position in Balchem Corporation by 9.7% in the 2nd quarter. Fred Alger Management Inc. now owns 230,801 shares of the basic materials company’s stock valued at $17,936,000 after buying an additional 20,366 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in Balchem Corporation by 61.7% in the 2nd quarter. Goldman Sachs Group Inc. now owns 40,327 shares of the basic materials company’s stock valued at $3,133,000 after buying an additional 15,385 shares during the last quarter. Tudor Investment Corp ET AL purchased a new position in Balchem Corporation in the 2nd quarter valued at about $376,000. Voya Investment Management LLC boosted its position in Balchem Corporation by 8.7% in the 2nd quarter. Voya Investment Management LLC now owns 14,495 shares of the basic materials company’s stock valued at $1,126,000 after buying an additional 1,160 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in Balchem Corporation by 1.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 723,504 shares of the basic materials company’s stock valued at $56,223,000 after buying an additional 8,869 shares during the last quarter. 84.22% of the stock is owned by institutional investors.
Balchem Corporation (NASDAQ BCPC) opened at 81.73 on Wednesday. The stock has a market capitalization of $2.61 billion, a PE ratio of 42.35 and a beta of 1.12. The firm has a 50-day moving average of $77.91 and a 200-day moving average of $78.59. Balchem Corporation has a 52-week low of $67.71 and a 52-week high of $89.50.
Balchem Corporation (NASDAQ:BCPC) last posted its earnings results on Friday, August 4th. The basic materials company reported $0.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.63 by $0.01. Balchem Corporation had a net margin of 10.99% and a return on equity of 14.99%. The business had revenue of $147.08 million for the quarter. On average, equities analysts expect that Balchem Corporation will post $2.47 EPS for the current year.
Separately, BidaskClub cut shares of Balchem Corporation from a “hold” rating to a “sell” rating in a research report on Wednesday, June 21st.
Balchem Corporation Profile
Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products.
What are top analysts saying about Balchem Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Balchem Corporation and related companies.